Information:
Fel:
ID
31244
Beskrivning
Changes in Ectopic Fat Following Surgically Induced Weight Loss; ODM derived from: https://clinicaltrials.gov/show/NCT00840307
Länk
https://clinicaltrials.gov/show/NCT00840307
Nyckelord
Versioner (1)
- 2018-08-01 2018-08-01 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
1 augusti 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Obesity NCT00840307
Eligibility Obesity NCT00840307
- StudyEvent: Eligibility
Similar models
Eligibility Obesity NCT00840307
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Age
Item
greater than 18 years old
boolean
C0001779 (UMLS CUI [1])
Comprehension Study Protocol | Protocol Compliance
Item
fully understanding and willing to undergo study procedures
boolean
C0162340 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C0525058 (UMLS CUI [2])
C2348563 (UMLS CUI [1,2])
C0525058 (UMLS CUI [2])
Patient Available Follow-up
Item
available for follow-up
boolean
C0030705 (UMLS CUI [1,1])
C0470187 (UMLS CUI [1,2])
C3274571 (UMLS CUI [1,3])
C0470187 (UMLS CUI [1,2])
C3274571 (UMLS CUI [1,3])
Informed Consent
Item
understand and willing to sign informed consent
boolean
C0021430 (UMLS CUI [1])
Pharmaceutical Preparations Changing Fat Contents | Pioglitazone | Pharmaceutical Preparations Dose Stable
Item
pharmacologic agents with the potential to change ectopic fat content (i.e. pioglitazone) are allowed if the patient has been on a stable dose for at least 3 months and plans to continue the same dose for the duration of the study
boolean
C0013227 (UMLS CUI [1,1])
C0392747 (UMLS CUI [1,2])
C0015677 (UMLS CUI [1,3])
C0456205 (UMLS CUI [1,4])
C0071097 (UMLS CUI [2])
C0013227 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0205360 (UMLS CUI [3,3])
C0392747 (UMLS CUI [1,2])
C0015677 (UMLS CUI [1,3])
C0456205 (UMLS CUI [1,4])
C0071097 (UMLS CUI [2])
C0013227 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0205360 (UMLS CUI [3,3])
Medical contraindication MRI | Claustrophobia Severe | Body Weight Pounds Quantity
Item
contraindication to mri (i.e. metallic implants, severe claustrophobia, weight above 320lb)
boolean
C1301624 (UMLS CUI [1,1])
C0024485 (UMLS CUI [1,2])
C0008909 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0005910 (UMLS CUI [3,1])
C0439219 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
C0024485 (UMLS CUI [1,2])
C0008909 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0005910 (UMLS CUI [3,1])
C0439219 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
Medical contraindication Venesection | Access Veins Lacking | Hemoglobin measurement
Item
contraindication to phlebotomy (i.e. no accessible veins, hemoglobin <10 mg/dl)
boolean
C1301624 (UMLS CUI [1,1])
C0684257 (UMLS CUI [1,2])
C0444454 (UMLS CUI [2,1])
C0042449 (UMLS CUI [2,2])
C0332268 (UMLS CUI [2,3])
C0518015 (UMLS CUI [3])
C0684257 (UMLS CUI [1,2])
C0444454 (UMLS CUI [2,1])
C0042449 (UMLS CUI [2,2])
C0332268 (UMLS CUI [2,3])
C0518015 (UMLS CUI [3])
Pancreatic Disease | Exception Diabetes Mellitus
Item
history of pancreatic disease other than diabetes
boolean
C0030286 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0011849 (UMLS CUI [2,2])
C1705847 (UMLS CUI [2,1])
C0011849 (UMLS CUI [2,2])
Consumption Alcoholic drinks Number per day
Item
regular use of more than 2 alcoholic drinks per day
boolean
C0001948 (UMLS CUI [1,1])
C0001967 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,3])
C0439505 (UMLS CUI [1,4])
C0001967 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,3])
C0439505 (UMLS CUI [1,4])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Lacking Able to speak English Language
Item
non-english speaking
boolean
C0332268 (UMLS CUI [1,1])
C0564215 (UMLS CUI [1,2])
C0376245 (UMLS CUI [1,3])
C0564215 (UMLS CUI [1,2])
C0376245 (UMLS CUI [1,3])